Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             60 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 An internet-based survey of synesthesia in multiple sclerosis: Incidence, characteristics and implications Propper, Ruth E.

54 C p.
artikel
2 A patient with concurrent multiple sclerosis and moyamoya disease Koul, Prateeka

54 C p.
artikel
3 Association between MS-related knowledge, health literacy, self-efficacy, resilience, and quality of life in a large cohort of MS community members: A cross-sectional study Claflin, Suzi B.

54 C p.
artikel
4 A variant of uncertain significance in SDHAF1, the succinate dehydrogenase chaperone protein, in an adult patient with spastic paraparesis and leukoencephalopathy Vlahovic, L.

54 C p.
artikel
5 Averting multiple sclerosis long-term societal and healthcare costs: The Value of Treatment (VoT) project Tinelli, Michela

54 C p.
artikel
6 Barriers and motivators for tobacco smoking cessation in people with multiple sclerosis Hunter, Assunta

54 C p.
artikel
7 Beneficial effects of a nano formulation of pomegranate seed oil, GranaGard, on the cognitive function of multiple sclerosis patients Petrou, Panayiota

54 C p.
artikel
8 Biomarkers of systemic inflammation, soluble IL-2Rα and the multiple sclerosis-associated IL2RA SNP rs2104286 in healthy subjects and multiple sclerosis patients Buhelt, Sophie

54 C p.
artikel
9 Brain volume change after high-dose immunosuppression and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis Lee, Hyunwoo

54 C p.
artikel
10 Cannabinoids and bladder symptoms in multiple sclerosis Kim-Fine, Shunaha

54 C p.
artikel
11 Cardiovascular risk estimated in individuals with multiple sclerosis: A case-control study Albuquerque, Larissa da Silva

54 C p.
artikel
12 Changes on the health care of people with multiple sclerosis from Latin America during the COVID-19 pandemic Chertcoff, Anibal

54 C p.
artikel
13 Characteristics of mHealth app use in an international sample of people with multiple sclerosis Bevens, W

54 C p.
artikel
14 Circulating levels of tight junction proteins in multiple sclerosis: Association with inflammation and disease activity before and after disease modifying therapy Olsson, A.

54 C p.
artikel
15 Cognitive fatigability in multiple sclerosis: How does performance decline over time on the Paced Auditory Serial Addition Test? Agyemang, Cathy

54 C p.
artikel
16 Conus medullaris involvement in demyelinating disorders of the CNS: A comparative study Etemadifar, Masoud

54 C p.
artikel
17 Corrigendum to ’ Optical Coherence Tomography in Neuromyelitis Optica spectrum disorder and Multiple Sclerosis: A population-based study’ [Multiple Sclerosis and Related Disorders Volume 47 (2021) 1–8/ 102625] Ashtari, Fereshteh

54 C p.
artikel
18 COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021 Ehde, Dawn M.

54 C p.
artikel
19 Delaying the inevitable: Are disease modifying drugs for progressive MS worthwhile? Burman, Joachim

54 C p.
artikel
20 Differences in correlates of fatigue between relapsing and progressive forms of multiple sclerosis Herring, Tracy E.

54 C p.
artikel
21 Distinct patterns of MRI lesions in MOG antibody disease and AQP4 NMOSD: a systematic review and meta-analysis Carandini, Tiziana

54 C p.
artikel
22 Does health-related quality of life differ between people with relapse onset and progressive onset Multiple Sclerosis? Ahmad, Hasnat

54 C p.
artikel
23 Early predictors of conversion to secondary progressive multiple sclerosis Barzegar, Mahdi

54 C p.
artikel
24 Effectiveness of Virtual Reality Rehabilitation in Persons with Multiple Sclerosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials Nascimento, Andréia Santos

54 C p.
artikel
25 End of life in multiple sclerosis: Disability, causes and place of death among cases diagnosed from 1981 to 2010 in Pirkanmaa hospital district in Western Finland Murtonen, Annukka

54 C p.
artikel
26 Ethical considerations in the treatment of multiple sclerosis fatigue Nourbakhsh, Bardia

54 C p.
artikel
27 Evaluation of remote assessments for multiple sclerosis in an in-home setting Kuri, Ashvin

54 C p.
artikel
28 Excess weight, central adiposity and pro-inflammatory diet consumption in patients with neuromyelitis optica spectrum disorder Paz, Éllen Sousa

54 C p.
artikel
29 Fear of relapse in patients suffering from RRMS influence their quality of life Khatibi, Ali

54 C p.
artikel
30 Five-year real-world data on fingolimod treatment's effects on cognitive function Ozakbas, S.

54 C p.
artikel
31 Frequency and characteristics of falls in people living with and without multiple sclerosis during the COVID-19 pandemic: A cross-sectional online survey Zanotto, Tobia

54 C p.
artikel
32 Higher Framingham Risk Scores are associated with greater loss of brain volume over time in multiple sclerosis Marrie, Ruth Ann

54 C p.
artikel
33 How not to get your article published Hawkes, CH

54 C p.
artikel
34 Humoral response to SARS-CoV-2 COVID-19 vaccines in patients with multiple sclerosis treated with immune reconstitution therapies Drulovic, Jelena

54 C p.
artikel
35 Is computerized screening for processing speed impairment sufficient for identifying MS-related cognitive impairment in a clinical setting? Galioto, Rachel

54 C p.
artikel
36 Key points to keep in mind related to COVID-19 vaccines in people with multiple sclerosis Galleguillos, Lorna

54 C p.
artikel
37 Multiple sclerosis epidemiology in Asia and Oceania; A systematic review and meta-analysis Forouhari, Ali

54 C p.
artikel
38 Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia Stastna, Dominika

54 C p.
artikel
39 Myelin content changes in Clinically Isolated Syndrome and Relapsing- Remitting Multiple Sclerosis: Associations with lesion type and severity of visuomotor impairment Panou, Τheodora

54 C p.
artikel
40 Natural history of relapsing remitting multiple sclerosis in a long-lasting cohort from a tertiary MS centre in Portugal Sá, Maria José

54 C p.
artikel
41 No significant differences in absenteeism or academic achievements in a Norwegian multiple sclerosis case control study Simonsen, Cecilia Smith

54 C p.
artikel
42 Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine Moniz Dionísio, Joana

54 C p.
artikel
43 Oral administration of methylprednisolone powder for intravenous injection dissolved in water to treat MS and NMOSD relapses during COVID-19 pandemic in a real-world setting Luetic, Geraldine G.

54 C p.
artikel
44 Oral pulsed therapy of relapsing multiple sclerosis with cladribine tablets – expert opinion on issues in clinical practice Stangel, Martin

54 C p.
artikel
45 Performance of highly cited multiple sclerosis publications in the Science Citation Index expanded: A scientometric analysis Ho, Yuh-Shan

54 C p.
artikel
46 Potential prognostic value of circulating inflamma-miR-146a-5p and miR-125a-5p in relapsing-remitting multiple sclerosis Giuliani, Angelica

54 C p.
artikel
47 Psychological well-being in people with multiple sclerosis and its association with illness perception and self-esteem Timkova, Vladimira

54 C p.
artikel
48 Quantification of smooth pursuit dysfunction in multiple sclerosis Rempe, Torge

54 C p.
artikel
49 Relapses shortly after rituximab treatment in neuromyelitis optica spectrum disorder Shi, Bingxin

54 C p.
artikel
50 Review of Phase III Clinical Trials Outcomes in Patients with Secondary Progressive Multiple Sclerosis McAdams, Matthew

54 C p.
artikel
51 Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice Valentino, Paola

54 C p.
artikel
52 Should we still only rely on EDSS to evaluate disability in multiple sclerosis patients? A study of inter and intra rater reliability Cohen, Mikael

54 C p.
artikel
53 Standardizing fatigue measurement in multiple sclerosis: the validity, responsiveness and score interpretation of the PROMIS SF v1.0 – Fatigue (MS) 8a Kamudoni, Paul

54 C p.
artikel
54 Susceptibility weighted imaging detects prominent veins that precede or coincide with maximal motor disability in a model of multiple sclerosis: A pilot study Nathoo, Nabeela

54 C p.
artikel
55 The frequency of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-IgG-negative neuromyelitis optica spectrum disorders patients in Latin America Carnero Contentti, Edgar

54 C p.
artikel
56 The importance of assessing life stress exposure in multiple sclerosis: A case report Polick, Carri S.

54 C p.
artikel
57 Validating the walking while talking test to measure motor, cognitive, and dual-task performance in ambulatory individuals with multiple sclerosis Henning, David A.

54 C p.
artikel
58 Vascular endothelial dysfunction associated with severity in multiple sclerosis Senzaki, Kensuke

54 C p.
artikel
59 What telomeres teach us about MS Miner, Annalise E.

54 C p.
artikel
60 Work productivity trajectories of Australians living with multiple sclerosis: A group-based modelling approach Bessing, Barnabas

54 C p.
artikel
                             60 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland